Signal2026-07-24
ClinicalTrials.gov

[PHASE2] Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical Trial

Part of

Molecular Profiling In Endocrine Neoplasms